Contraception with subcutaneous capsules containing ST-1435. Pituitary and ovarian function and plasma levels of ST-1435
- 31 January 1981
- journal article
- Published by Elsevier in Contraception
- Vol. 23 (1) , 63-75
- https://doi.org/10.1016/0010-7824(81)90115-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Clinical trial with subdermal implants containing norgestrienoneContraception, 1978
- A semi-automated radioimmunoassay technique employing a nine-channel pipetting and sample handlingScandinavian Journal of Clinical and Laboratory Investigation, 1978
- Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrelContraception, 1976
- Contraception with megestrol acetate implants. Megestrol acetate levels in plasma and the influence on the ovarian functionContraception, 1976
- Clinical assessment of subdermal implants of megestrol acetate, d-norgestrel, and norethindrone as a longterm contraceptive in womenContraception, 1975
- Contraceptive effectiveness of silastic: Implants containing the progestin R-2323Contraception, 1975
- A preliminary report on the contraceptive use of subdermal implants containing norethindroneContraception, 1974
- Radioimmunoassay of norethindrone: Peripheral plasma levels after oral administration to humans and rhesus monkeysContraception, 1974
- Specificity of antibodies to ovarian hormones in relation to the site of attachment of the steroid hapten to the peptide carrierSteroids, 1972
- Radioimmunoassay of serum progesterone in women receiving oral contraceptive steroidsContraception, 1972